Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating periostin in patients with nonalcoholic fatty liver disease.
Polyzos SA, Kountouras J, Anastasilakis AD, Papatheodorou A, Kokkoris P, Terpos E. Polyzos SA, et al. Among authors: kokkoris p. Endocrine. 2017 May;56(2):438-441. doi: 10.1007/s12020-016-1144-x. Epub 2016 Oct 13. Endocrine. 2017. PMID: 27738886 No abstract available.
Periostin and sclerostin levels in juvenile Paget's disease.
Polyzos SA, Makras P, Anastasilakis AD, Mintziori G, Kita M, Papatheodorou A, Kokkoris P, Terpos E. Polyzos SA, et al. Among authors: kokkoris p. Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):269-271. doi: 10.11138/ccmbm/2017.14.2.269. Epub 2017 Oct 25. Clin Cases Miner Bone Metab. 2017. PMID: 29263750 Free PMC article.
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.
Anastasilakis AD, Polyzos SA, Makras P, Gkiomisi A, Sakellariou G, Savvidis M, Papatheodorou A, Kokkoris P, Terpos E. Anastasilakis AD, et al. Among authors: kokkoris p. Expert Opin Ther Targets. 2015 Mar;19(3):299-306. doi: 10.1517/14728222.2014.983078. Epub 2014 Nov 14. Expert Opin Ther Targets. 2015. PMID: 25395071 Clinical Trial.
Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
Anastasilakis AD, Polyzos SA, Efstathiadou ZA, Savvidis M, Sakellariou GT, Papatheodorou A, Kokkoris P, Makras P. Anastasilakis AD, et al. Among authors: kokkoris p. Metabolism. 2015 Oct;64(10):1291-7. doi: 10.1016/j.metabol.2015.06.018. Epub 2015 Jun 27. Metabolism. 2015. PMID: 26198440 Clinical Trial.
29 results